CANCER Cancer
$0.0001
$0.059550
(7.53%)
Mkt Cap$118,650.00
Vol1,188.78
About Cancer
Astrofolio taps into current cultural trends by referencing memes and popular narratives within the crypto space. It allows users to speculate on or invest in cryptocurrencies based on astrological signs, which is a novel approach in the crypto space. This fusion of ancient wisdom with modern financial technology creates a unique niche for enthusiasts of both fields. Cancer, the Crab , captures the nurturing and protective energy of early summer, from mid-June to mid-July. Known for its emotional depth and loyalty, Cancer season is a time to focus on home and family. Connect with the intuitive and compassionate spirit of Cancer!
Pfizer (PFE) Stock Surges to 52-Week Peak Following Strong Q2 Results and Major Legal Settlement
Pfizer (PFE) stock touched a 52-week high of $29.09 after Q2 earnings exceeded forecasts and the company settled over 6,000 Depo-Provera lawsuits. The post Pfizer (PFE) Stock Surges to 52-Week Peak Following Strong Q2 Results and Major Legal Settlement appeared first on Blockonom...
Blockonomi
BioAffinity Technologies (BIAF) Stock Jumps 55% on CyPath Lung Cancer Survivor Monitoring News
BioAffinity Technologies (BIAF) stock rallied 55% after revealing CyPath Lung's potential to monitor lung cancer survivors for recurrence. Volume hit 17M shares. The post BioAffinity Technologies (BIAF) Stock Jumps 55% on CyPath Lung Cancer Survivor Monitoring News appeared first...
Blockonomi
Agenus Inc. (AGEN) Stock: BOT+BAL Delivers 21.2-Month Survival in Colorectal Cancer Trial
TLDR BOT+BAL delivers 21.2-month median survival in refractory MSS colorectal cancer. Three-year overall survival reaches 33% in Agenus’ fully enrolled Phase 1b cohort. Confirmed response rate hits 21%, including three complete and 23 partial responses. BOT+BAL responses appear e...
Blockonomi
BioNTech (BNTX) Shares Plunge 8% Following Colorectal Cancer Vaccine Trial Discontinuation
BioNTech (BNTX) shares dropped 8% after discontinuing its Phase 2 mRNA colorectal cancer vaccine trial due to futility and survival imbalances. The post BioNTech (BNTX) Shares Plunge 8% Following Colorectal Cancer Vaccine Trial Discontinuation appeared first on Blockonomi.
Blockonomi
Moderna (MRNA) Stock Drops 4.6% Despite Groundbreaking Cancer Vaccine Breakthrough
Moderna (MRNA) stock fell 4.6% Friday despite breakthrough cancer vaccine results. Analysts project $3B sales by 2035. Price targets range $74-$135. The post Moderna (MRNA) Stock Drops 4.6% Despite Groundbreaking Cancer Vaccine Breakthrough appeared first on Blockonomi.
Blockonomi
Revolution Medicines (RVMD) Stock Climbs After Early FDA Green Light for Pancreatic Cancer Treatment
Revolution Medicines (RVMD) stock gained after the FDA granted early approval to Rasonque for pancreatic cancer, with trial data showing significant survival benefits. The post Revolution Medicines (RVMD) Stock Climbs After Early FDA Green Light for Pancreatic Cancer Treatment ap...
Blockonomi
Johnson & Johnson (JNJ) Stock: Surge as FDA Approval and European Cancer Treatment Expansion Drive Market Attention
TLDR Johnson & Johnson gains momentum after FDA approves Imaavy for rare blood disorder. JNJ expands cancer care reach after Europe approves Tecvayli combination treatment. New approvals strengthen Johnson & Johnson’s growing immunology and oncology portfolio. Imaavy and Tecvayli...
Blockonomi
Moderna (MRNA) Stock Soars 14% on Personalized Cancer Vaccine Success: Is It Time to Buy?
Moderna (MRNA) stock jumps 14% as its personalized mRNA cancer vaccine meets Phase 3 trial goals. Analysts boost price targets, but is the rally sustainable? The post Moderna (MRNA) Stock Soars 14% on Personalized Cancer Vaccine Success: Is It Time to Buy? appeared first on Block...
Blockonomi
Moderna, Inc. (MRNA) Stock: Jefferies Sees $54B Peak Sales for Cancer Therapy
TLDR Moderna shares plunged 24.56% despite positive Phase III melanoma trial results. Jefferies models $54 billion in global peak sales for Moderna’s cancer therapy. The melanoma study met recurrence-free and distant metastasis-free endpoints. Jefferies raised Moderna’s price tar...
Blockonomi
Moderna Shares Surge on Cancer Drug News as Bitcoin and Gold Also Rally
A single evening saw sharp gains across biotech, crypto and precious metals, according to market digests from Invezz and Yahoo Finance. Moderna's stock price surged after the company reported a breakthrough tied to a cancer drug, according to Yahoo Finance. The outlet cited a 177...
TheCoinrise
Bullish/Bearish Forum Sentiment
Indicates whether most users posting on a crypto’s stream over the last 24 hours are bearish or bullish.
0
25
50
75
100
Extremely
Bearish
Neutral
Bullish
Extremely
Bearish
Bullish
N/A
Last score
N/A
1 day ago
Sign Up / Log In
1 week ago
Sign Up / Log In
1 month ago
Sign Up / Log In
3 months ago
Sign Up / Log In
6 months ago
Sign Up / Log In
1 year ago
Sign Up / Log In
Message Board Activity
Measures the total amount of chatter on a stream over the last 24 hours.
0
25
50
75
100
Extremely
Low
Normal
High
Extremely
Low
High
N/A
Last score
N/A
1 day ago
Sign Up / Log In
1 week ago
Sign Up / Log In
1 month ago
Sign Up / Log In
3 months ago
Sign Up / Log In
6 months ago
Sign Up / Log In
1 year ago
Sign Up / Log In
Discussion Diversity
Measures the number of unique accounts posting on a stream relative to the number of total messages on that stream.
0
25
50
75
100
Extremely
Low
Normal
High
Extremely
Low
High
N/A
Last score
N/A
1 day ago
Sign Up / Log In
1 week ago
Sign Up / Log In
1 month ago
Sign Up / Log In
3 months ago
Sign Up / Log In
6 months ago
Sign Up / Log In
1 year ago
Sign Up / Log In
Date
Market Cap
Volume
Close
September 03, 2026
$118,635.75
$1,188.81
---
September 03, 2026
$132,379.15
$755.29
---
September 02, 2026
$135,872.87
$1,835.14
$0.0001
September 01, 2026
$148,248.64
$913.10
$0.0001
August 31, 2026
$147,296.96
$431.77
$0.0001
August 30, 2026
$155,935.14
$861.07
$0.0002
August 29, 2026
$160,834.91
$1,090.21
$0.0002
August 28, 2026
$175,368.06
$1,437.16
$0.0002
August 27, 2026
$167,855.31
$718.70
$0.0002
August 26, 2026
$162,106.43
$7,525.66
$0.0002
Fundamentals
50
Neutral Sentiment
How do you feel about CANCER?
Advertisement|Remove ads.
Latest CANCER News
ViewPfizer (PFE) Stock Surges to 52-Week Peak Following Strong Q2 Results and Major Legal Settlement
Blockonomi
BioAffinity Technologies (BIAF) Stock Jumps 55% on CyPath Lung Cancer Survivor Monitoring News
Blockonomi
Agenus Inc. (AGEN) Stock: BOT+BAL Delivers 21.2-Month Survival in Colorectal Cancer Trial
Blockonomi
